The electrophysiological effects of amiodarone were studied in guinea pig papillary muscle by means of the single sucrose gap voltage clamp technique. The first time derivative of the upstroke of the action potential was measured as an indicator of the sodium current. The preparations were not voltage clamped during the action potential upstroke. Acute effects of amiodarone (4.4 x 10~5 M and 8.8 x 10~5 M; six experiments each) and effects of chronic administration at a single dose level (nine experimental vs. eight control animals) were studied. Results were qualitatively the same for all experimental conditions, and concentration dependent in the acute studies. Amiodarone caused marked use-dependent depression of the first rime derivative of the upstroke of the action potential during stimulus trains. For example, at normal resting potential, chronic amiodarone treatment reduced the first time derivative of the upstroke of the action potential of the 16th beat of trains of cycle length 300 msec to 70 ± 15% (mean ± SD) of the initial value. This blocking effect was accentuated at more depolarized holding potentials and reduced at hyperpolarized holding potentials. Reduction of the first time derivative of the upstroke of the action potential was found to depend upon sodium channel inactivation. For all experiments, the mean normalized first time derivative of the upstroke of the action potential following a 1-second clamp in the -20 to +20 mV range was 0.92 ± 0.08 in the control condition and 0.66 ± 0.20 in the presence of amiodarone (<0.01). The reduction of the first time derivative of the upstroke of the action potential by amiodarone could be minimized by shortening the action potential plateau, and exaggerated by lengthening the plateau with a voltage clamp to potentials at which all channels are inactivated. Recovery from block by amiodarone at the resting potential (about -85 mV) had a time constant of 1.63 ± 0.24 sec. Over the -100 to -65 mV range, this time constant was moderately shortened by hyperpolarization and lengthened by depolarization. Analysis of the data in a computer model of the state-dependent interaction of drugs with the cardiac sodium channel yielded the following dissociation constants: rested state > 0.1 M, activated state = 10~3 M, and inactivated state = 2 x 10~5 M. Amiodarone also prolonged action potential duration and consistently inhibited depolarization-induced automaticity in all experimental conditions. We conclude that amiodarone is a potent sodium channel blocker and that a major mechanism of its action is selective affinity for sodium channels in the inactivated state. (Circ Res 55: 277-285, 1984) 
SUMMARY. The electrophysiological effects of amiodarone were studied in guinea pig papillary muscle by means of the single sucrose gap voltage clamp technique. The first time derivative of the upstroke of the action potential was measured as an indicator of the sodium current. The preparations were not voltage clamped during the action potential upstroke. Acute effects of amiodarone (4.4 x 10~5 M and 8.8 x 10~5 M; six experiments each) and effects of chronic administration at a single dose level (nine experimental vs. eight control animals) were studied. Results were qualitatively the same for all experimental conditions, and concentration dependent in the acute studies. Amiodarone caused marked use-dependent depression of the first rime derivative of the upstroke of the action potential during stimulus trains. For example, at normal resting potential, chronic amiodarone treatment reduced the first time derivative of the upstroke of the action potential of the 16th beat of trains of cycle length 300 msec to 70 ± 15% (mean ± SD) of the initial value. This blocking effect was accentuated at more depolarized holding potentials and reduced at hyperpolarized holding potentials. Reduction of the first time derivative of the upstroke of the action potential was found to depend upon sodium channel inactivation. For all experiments, the mean normalized first time derivative of the upstroke of the action potential following a 1-second clamp in the -20 to +20 mV range was 0.92 ± 0.08 in the control condition and 0.66 ± 0.20 in the presence of amiodarone (<0.01). The reduction of the first time derivative of the upstroke of the action potential by amiodarone could be minimized by shortening the action potential plateau, and exaggerated by lengthening the plateau with a voltage clamp to potentials at which all channels are inactivated. Recovery from block by amiodarone at the resting potential (about -85 mV) had a time constant of 1.63 ± 0.24 sec. Over the -100 to -65 mV range, this time constant was moderately shortened by hyperpolarization and lengthened by depolarization. Analysis of the data in a computer model of the state-dependent interaction of drugs with the cardiac sodium channel yielded the following dissociation constants: rested state > 0.1 M, activated state = 10~3 M, and inactivated state = 2 x 10~5 M. Amiodarone also prolonged action potential duration and consistently inhibited depolarization-induced automaticity in all experimental conditions. We conclude that amiodarone is a potent sodium channel blocker and that a major mechanism of its action is selective affinity for sodium channels in the inactivated state. (Circ Res 55: 277-285, 1984) AMIODARONE is an effective antiarrhythmic agent (Rosenbaum et al., 1976 , Heger et al., 1981 , Nademanee et al., 1981 , Kaski et al., 1981 , Waxman et al., 1982 Fogoros et al., 1983) . A previous study showed that amiodarone prolonged action potential duration in rabbit atrial and ventricular myocardium, but did not significantly alter the first time derivative of the ventricular action potential upstroke (Vma,) under the experimental conditions used (Singh and Vaughan Williams, 1970) . However, in clinical studies, amiodarone has been found to pro-long the His-to-ventricular conduction time and to worsen pre-existing bundle branch block (Heger et al., 1981) . Reduction of conduction velocity in the His-Purkinje system can result from sodium channel block (Gerstenblith et al., 1970) . We therefore examined the hypothesis that amiodarone blocks sodium channels of cardiac ventricular muscle. We reported briefly on the effects of acute administration of amiodarone in a guinea pig papillary muscle preparation, and showed that this drug was a potent blocker of inactivated sodium channels (Mason et 278 al., 1983) . However, amiodarone is clinically most effective after chronic administration, and its acute efficacy is controversial in humans (Nademanee et al., 1983) . Therefore, in the present paper, we examine in greater detail and compare to our previous findings the effects of chronically administered amiodarone and of a smaller acute concentration of amiodarone.
Methods
Guinea pigs were killed by cervical dislocation. Papillary muscles having a diameter less than 1 mm were dissected from the right or left ventricles and mounted in a single sucrose gap chamber (Hondeghem and Katzung, 1980) so that less than 1 mm of myocardium protruded into the test compartment. Previous studies in this preparation have shown that membrane potentials measured at two different sites differ little, except during the upstroke (New and Trautwein, 1972; Katzung and Morgenstern, 1977) . Solutions maintained at 35-37°C continuously perfused the gap compartments. The rear chamber contained an isotonic potassium chloride solution. The middle chamber was perfused with an isotonic sucrose solution, enriched with 5 mvi glucose and 0.025 mM CaCl 2 . The test chamber was perfused at about 10 ml/min with a solution having the following composition: NaCl, 145 mM; KC1, 4 miu; MgCl 2 , 1.1 mM; CaCh, 1.8 mM; and 5 mM HEPES. It was titrated to a pH of 7.4 and all solutions were gassed with 100% oxygen.
Twenty-one guinea pigs were studied. Nine received amiodarone, 20 mg/kg, intraperitoneally, 5 days per week for a total of at least 28 doses. Papillary muscles from these animals were removed 1 day after the last injection used in the in vitro experiments referred to below as "chronic" experiments. These preparations were not exposed to amiodarone in the superfusate, but showed drug effects because of the very slow washout of the agent. Eight served as chronic control animals and received sterile saline on the same schedule. These eight guinea pigs and four additional animals which had received no chronic injections provided the papillary muscles for study of amiodarone administered in the superfusate, referred to below as 'acute* experiments. In six of the 12 acute experiments a high concentration (8.8 X 10~, 5 M) was tested and in the other six a lower (4.4 x 10" 5 M) concentration was evaluated. The six studies of acute amiodarone administration at high concentration were partially reported upon, previously . Additional findings from those experiments, and comparisons to chronic administration of amiodarone and acute administration of a lower concentration of amiodarone, are reported here.
In the concentrations used in the acute experiments, amiodarone forms a suspension when added to physiological saline. To reduce precipitation, bovine albumin (1%) was added to the Tyrode's solution. Although this eliminated the visible cloudiness of the solution of low concentration, it did not completely prevent formation of a suspension in the solution of high amiodarone concentration. The nature of the suspension which forms when amiodarone is added to Tyrode's solution is unknown. However, its presence did not appear to prevent amiodarone's action, since the drug effect increased with the higher concentration.
In three experiments, control studies were done before Circulation Research/Vol. 55, No. 3, September 1984 and after addition of albumin to the Tyrode's solution; albumin did not affect any measured variables. Data derived from muscles obtained from chronic animals were recorded within 3 hours of cardiectomy. The acute effects of amiodarone were determined during a 60to 90-minute period beginning 30 minutes after amiodarone entered the test chamber.
Myocardial cells in the test chamber were impaled with KC1 (3 M)-filled standard glass microelectrodes connected to a high impedance, variable capacitance neutralization amplifier, adjusted for optimum square wave response to current injected at the amplifier headstage. The maximum rate of change of membrane potential during action potential upstrokes (V^) was measured with a sample and hold peak detector (Hondeghem and Corner, 1978) . The action potential, its first derivative, and the output of the peak detector were continously monitored on an oscilloscope. V™, was recorded on a polygraph, together with the transmembrane potential and the membrane current. Membrane current was used only to monitor the stability of the clamped preparation.
Clamp pulses were controlled by a microprocessorbased stimulator (Hondeghem and Ehring, 1982) . Four stimulation protocols were used. The first protocol was designed to evaluate use-dependent sodium channel block by amiodarone during stimulus trains. Each train included 19 beats. Seven different interstimulus intervals (cycle lengths) were used: 300, 400, 600, 1000, 1800, 3400, and 6600 msec. In some trains, the diastolic holding potential (V h ) and the plateau potential (V p i) were controlled by voltage clamp to selected levels for selected periods of time. Action potentials were elicited with constant current stimuli of 2 msec duration. The current amplitude was adjusted to limit variations in latency (between the beginning of the stimulus and V ma ») to less than 1 msec (Walton and Fozzard, 1979) . The voltage clamp was released (by switching to current clamp) for a 5-msec period after each stimulus to allow a free-running upstroke. To assess the extent of depression of the upstroke during trains, V max of each pulse of the train was normalized to that of the first beat of the train.
The second stimulation protocol (see inset, Fig. 2 ) was designed to assess the relative contributions of activationdependent and inactivation-dependent blockade by amiodarone. A single conditioning plateau clamp preceded the test stimulus. The plateau clamp potential was varied between -50 and +45 mV, and the duration was varied from 10 to 6600 msec. The test stimulus, adjusted to maintain constant latency, followed the conditioning plateau clamp after a 50-msec period during which membrane potential was clamped to the holding level (-80 to -85 mV) to remove physiological inactivation. V ma% was measured during the free-running upstroke elicited by the test stimulus. Each conditioning pulse was preceded by a 20-second rest period and arose from the same V h as the test pulse.
The third stimulation protocol was used to evaluate recovery from use-dependent block by amiodarone. After a 20-second pause, a conditioning train of 19 beats at a cycle length of 300 msec was imposed. At.the end of the conditioning train, a test beat was elicited after varying recovery intervals. The membrane potential was voltage clamped to the holding potential during the stimulus trains and the recovery interval, whereas upstroke and plateau were not clamped for 180 msec. The depression V^, of the recovery pulse was calculated using the formula (V max . basic -V max .,est) •*• V max . basic , where V max . basic represents the basic or steady state V max of the first beat of the conditioning train after a 20-second rest period, and V ma ».test represents the recovery test pulse.
The fourth stimulation protocol ( Fig. 6 ) tested the effects of amiodarone upon depolarization-induced automaticity (Grant and Katzung, 1976 ). Constant-current pulses of 6.6-second duration were applied to shift maximum diastolic membrane potential to between -75 and +10 mV. Each current pulse was followed by a 20-second pause.
Statistical Analysis
Data are reported as mean ± 1 SD. Differences between two means were compared using paired and unpaired ttests. P values are based on two tails of the t-distribution. Comparison between multiple means was done using an analysis of variance. Significance in contingency table analysis was determined with Fischer's exact test. Statedependent dissociation constants (Hondeghem and Katzung, 1977) were estimated using a least square direct search solution (Moyer and Hondeghem, unpublished; Hooke and Jeeves, 1961) .
Results

Use-Dependent Block
Papillary muscles from the eight chronic control animals and the four untreated animals yielded similar results in the control condition (before in vitro drug perfusion) in response to the first stimulation protocol described above: a minimal decline in V max during trains of short cycle length, and no change during trains of longer cycle length. These control data are summarized in the three graphs on the left of Figure 1 , and are compared to the effects of amiodarone on the right. In all experimental conditions, amiodarone caused a progressive decline in V max during stimulus trains. During the 19-beat pulse train, full steady state block was not reached. The reduction of V max was most marked in trains of short cycle length. The extent of depression of V max in the papillary muscles exposed to amiodarone chronically was similar to that in those superfused in vitro with the high concentration of amiodarone. The effect was less, but still statistically significant, at the lower concentration. In the chronic amiodarone experiments, but not in the superfusion studies, V max of the second beat of trains of cycle length 300 msec was more markedly reduced than that of several subsequent pulses. This can be explained by the more marked increase in action potential duration that occurred in the chronically treated papillary muscles (see below).
The effect of variation of the holding potential upon V max was assessed in five studies of muscles from chronically treated animals using the first stimulation protocol. In these studies, a stimulation cycle length of 300 msec was used, and 180 msec after the beginning of each free-running action potential, V h was fixed first at a value that resulted in a moderate reduction of V max (i.e., between -65 and -75 mV), and then at a value close to the resting 279 potential [i.e., between -80 and -90 mV (see Table  1) ]. Normalized V max was more markedly depressed at the less negative holding potential. The reduction of V max had not reached steady state during the 19beat pulse trains, and at the end of trains it was still developing faster in the more depolarized tissue. When comparing the V max of the 16th beat at both potentials, the reduction was significantly larger (P < 0.02) in the more depolarized tissue; the difference would have been greater if steady state blockade had been achieved. The extent of use-dependent block declined progressively with increased hyperpolarization of the holding potential below -90 mV, but was not totally eliminated even at the maximum achievable holding potential of -140 mV.
As noted above, preparations from chronically treated animals manifested a greater than expected reduction of V max of the second action potential of stimulus trains (Fig. 1, top right) . This extra reduction was associated with prolongation of the duration of the first action potential following the 20second rest period. To test whether action potential duration is indeed an important factor in the development of amiodarone's use-dependent block, we used voltage clamp to alter the duration of the plateau phase of action potential during stimulus trains in eight experiments. First, action potentials were allowed to run free for 180 msec, after which they were clamped back to -80 mV. During the more rapid trains, V max slowly declined (see Fig. 1 , panel A, in Mason et al., 1983) . Then action potentials were allowed to run free for only 5 msec; immediately after the upstroke they were clamped back to -80 mV. Under these conditions, there was no reduction of V max during the pulse train. Finally, the plateau of each action potential was clamped to +20 mV for 180^350 msec before being clamped back to -80 mV. V max declined much more markedly (see Fig. 1, panel B , in Mason et al., 1983) . Similar observations were made in all eight experiments. Since no marked reduction of V max was observed during such clamp protocols in the absence of drugs, and since the time constant of recovery from block by amiodarone exceeds 1 second at -80 mV (see below), these data strongly suggest that a significant portion of the block caused by amiodarone develops during the plateau of the action potential.
Inactivation-Dependent Block
In order to evaluate the relative contributions of block by amiodarone occurring during activation and that occurring while sodium channels are inactivated, we studied the effects of action potential plateau level and duration, using the second stimulation protocol described above, and shown in the inset of Figure 2 . In the presence of amiodarone, Vmax was progressively depressed by increments in the duration of the plateau clamp. This effect, which was seen in muscles from pretreated animals, as well as in the low and high concentration acute experiments, has been illustrated previously (see Fig.  2 in Mason et al., 1983) . The effects of conditioning pulse duration were systematically studied in acute and chronic experi- ments with clamps up to 6.6 seconds in duration (Fig. 2) . Under control conditions, prolonged depolarization of cardiac cells results in a progressive reduction of V TO (Saikawa and Carmeliet, 1982; Clarkson et al., 1983) . This process can be approximated well by a single exponential with a time constant of about 4 second. In the presence of both acute concentrations and chronic amiodarone, Vmax decreases much faster and to a greater extent, and, as a function of inactivation clamp duration, the rate of decline requires two exponential terms for satisfactory approximation: a fast component, which has a time constant of about 130 msec, and a slower process similar to that of control.
To test whether the development of block by amiodarone during inactivation is voltage-depend- ent, the protocol shown in the Figure 2 inset was repeated at various conditioning clamp potentials between -30 and +25 mV in one acute and in four chronic amiodarone experiments. In none of these experiments did changes in the inactivation clamp potential alter the extent of fast or slow reduction of V m ax-The results of the four chronic amiodarone experiments are summarized in Figure 3 . The rate of reduction of V max at the more negative clamp levels was not different from that at more positive clamp potentials. As in the acute experiments, chronic amiodarone pretreatment resulted in a reduction of V max that increased with the length of the clamp.
Recovery from Block
The rate of recovery from block by amiodarone was assessed with the third stimulation protocol. Under drug-free conditions and at normal resting potentials, recovery from inactivation was usually complete in less than 10 msec. In the presence of amiodarone (Fig. 4) , partial recovery of V max occurs quickly, but a substantial fraction (about 40% in Fig.  4 ) recovers much more slowly. At -85 to -90 mV, this slow recovery process had a time constant of 163 ± 0.24 sec. The effects of amiodarone upon recovery from block were similar in the acute and chronic experiments.
The results presented indicate that the use-dependent depression of V max produced by amiodarone develops during inactivation and recovers during rest. The level of resting potential during the diastolic interval has been shown to influence the In four chronic studies, the plateau was clamped at a positive potential (high clamp) and a negative potential (low clamp) within the inactivation range. The high and low potential levels in the four experiments were, respectively, +21 and -22 mV, +17 and -22 mV, +15 and -6 mV, and +12 and -2 mV. Mean normalized V mat and standard deviation of the test pulses for the two clamp levels are plotted. There is no significant difference between the two curves.
blockade produced by other sodium channel-blocking drugs (Chen et al., 1975; Hondeghem and Katzung, 1977) . Thus, the voltage dependence of recovery during rest is reflected in the accumulation of block during regular trains at different resting potentials. Figure 5 shows the effect of V h on accumulation of block during the first 16 clamp pulses using the protocol shown in the inset (a variation of the first stimulation protocol). The amount of blockade achieved was much greater at -73 mV than at more negative holding potentials.
Depolarization-Induced Automaticity
In 11 of 15 control preparations, long depolarizing current pulses (the fourth stimulation protocol) induced runs of action potentials with rapid upstrokes from more negative potentials (Fig. 6A ) and slow upstrokes from less negative potentials (Fig. 6B ). In the presence of amiodarone, no depolarization-induced automaticity was elicited in 15 of 15 experiments (Fig. 6, C and D) . Nine of the latter 15 experiments were acute studies, in seven of which depolarization-induced automaticity had been present before supervision of the muscles with amiodarone.
Action Potential Duration
The duraton of action potentials was increased significantly by amiodarone in all the conditions Vmn-basic is the maximum upstroke velocity of fully recovered action potentials and V m0I .,,,/ refers to the test beats inserted at specific intervals (recovery times) after the conditioning train. The holding potential during the recovery intervals was -90 mV. The rate of recovery was greatly reduced by amiodarone.
used in the present study (Table 2 ; Fig. 7) . For statistical analysis, action potential duration was measured at 90% of full repolarization during steady state stimulation at 1 Hz. The measurement was obtained from the first stable impalement of papillary muscles from chronic animals, immediately before superfusion of amiodarone, and again immediately before initiation of stimulation studies during superfusion of amiodarone in the acute studies. In . Voltage dependence of recovery. V ma , of action potentials of trains (cycle length = 300 msec) at five different levels of V k from -73 to -109 mV demonstrate greater progressive accumulation of block at less negative holding potentials. The inset shows that only V k was altered during each train. Since the activation and inactivation-state binding of amiodarone would be expected to be identical at these holding potentials, the differences in the curves are best explained by slower recovery from block at less negative potentials. muscles from the chronic experiments, action potential duration was 48% longer in those exposed to amiodarone. In the low concentration superfusion studies, amiodarone increased action potential duration by 23%, and by 22% in the high concentration studies. Action potential duration was sufficiently prolonged in muscles from four of the animals which received amiodarone chronically that the second action potential elicited during stimulus trains of cycle length 300 msec arose from an incompletely repolarized potential. Rate-related reduction in action potential duration eliminated this effect during subsequent action potentials. As a result of more inactivation block, less recovery from block, and incomplete repolarization, the mean value of V max of the second action potential was lower than that of several subsequent action potentials (Fig. 1, top  right) .
Kinetics of Drug Action
The effect of amiodarone on V max develops slowly and progressively, and as a result it was not possible to obtain a steady state effect in our acute exposures. In three high-concentration acute experiments, we measured the development of amiodarone effect by applying a 19-beat pulse train (300-msec cycle length) at frequent intervals for up to 90 minutes after amiodarone entered the test compartment. A total of 22 trains (7, 7, and 8 in the three experiments) were applied. The time constants for decline of V max of the first and last beats of these trains were 130 and 88, 166 and 46, and 495 and 57 minutes, respectively. Similar differences for phasic and tonic block were recently described for propafenone (Kohlhardt and Seifert, 1983) , and these can be accounted for by the state-dependent model of antiarrhythmic drug action (Hondeghem, 1983) . 
Discussion
New data presented in this report demonstrate that amiodarone blocks cardiac sodium channels in chronically treated animals, as well as in preparations acutely superfused with two concentrations of the drug. Furthermore, this block is use-dependent in both chronic and acute preparations. Thus, at faster stimulation rates with action potential duration fixed by voltage clamp, the extent of block is greater. Recovery from amiodarone block is voltage dependent: it is slowed by depolarization and made faster by hyperpolarization. Therefore, for a given rate and action potential duration, amiodarone will depress conduction more in depolarized tissue than in normally polarized tissue. These results can be interpreted in terms of the Hille (1977) and Hondeghem and Katzung (1977) modulated receptor hypothesis. During each action potential, a fraction of the channels become blocked. During each diastolic interval, they slowly unblock. However, unlike quinidine, which causes use-dependent reduction of V max primarily through blockade of activated sodium channels (Hondeghem and Katzung, 1977; Colatsky, 1982; Weld et al., 1982) , amiodarone appears to have little affinity for activated channels. Indeed, when very short depolarizations were applied, even at fast rates, no reducton in V max could be observed. It is possible that amiodarone did block a very small fraction of the open channels, which then recovered during the 295-msec recovery interval. However, since the time constant of recovery from amiodarone block exceeds 1 second at -85 mV, the cumulative blocking effect of several activations should have been visible. Thus, if the concentrations of amiodarone used in the present experiment block activated channels at all, the amount of block per activation is very small.
In contrast, V max decreases as the inactivation period is prolonged, an effect that can be described by a double exponential function. The faster component of this function has a time constant of 100 to 200 msec, and can be observed only in the presence of amiodarone. We believe it results from amiodarone binding to inactivated channels. The slower component is also observed under control conditions, and probably reflects slow inactivation (Saikawa and Carmeliet, 1982; Clarkson et al., 1983) . The slow component appeared to be unmodified by amiodarone in the present experiments, although we did not study it in detail. The block by amiodarone was not voltage-dependent over the -30 to +40 mV range. This is distinctly different from the small component of inactivation block by quinidine, which has been reported to be strongly voltage dependent (Weld et al., 1982) .
Since neither the acute nor the chronic experiments resulted in a truly steady state drug effect, it was not possible to subject the data to a rigorous modulated receptor analysis. Nevertheless, as in our previous acute studies , least square error fits to the modulated receptor hypothesis (Hondeghem and Katzung, 1977) showed that amiodarone had a very low affinity for rested (Kj > 0.1 M) and activated (Kd -10" 3 M) sodium channels, but had a high affinity for inactivated channels (Kd -2 X 10~5 M). Estimates from the chronic studies resulted in similar values.
The nearly exclusive avidity of amiodarone for inactivated sodium channels may account in part for amiodarone's high antiarrhythmic efficacy. Amiodarone would be expected to depress selectively action potential upstrokes of cells with longer action potential durations. Thus, Purkinje fibers should be most markedly affected, and atrial fibers least. Interestingly, amiodarone may amplify its sodium channel effect by prolonging action potential duration. Furthermore, depolarized cells with resting membrane potential near the inactivation range (in ischemia, for example) would be more affected by amiodarone than normally polarized cells, regardless of action potential duration. In addition, recovery from depression of V max by amiodarone is slower in depolarized tissue. Blockade by amiodarone should be further enhanced by a tachysystole, because the inactivated/rested state ratio would be increased; slowed recovery would then lead to accumulation of block.
Block of inactivated sodium channels of neural tissue by amiodarone was suggested in a previous report (Revenko et al., 1980) . However, Singh and Vaughan Williams (1970) studied amiodarone in cardiac tissue and specifically denied the occurrence of an important degree of sodium channel block by amiodarone. They suggested that the drug's sole important effect was to prolong acton potential duration, and therefore classified it separately from drugs that depress V max . The discrepancy between their results and ours may be due to differences in experimental protocol or species used.
Amiodarone blocks sodium channels in a usedependent fashion and with a potency similar to quinidine and lidocaine. Thus, the unusual clinical efficacy of amiodarone probably results, in part, from its different mechanism of block compared to that of quinidine, which primarily blocks open channels (Hondeghem and Katzung, 1977, Weld et al., 1982) and of lidocaine, which blocks both open and inactivated channels (Hondeghem and Katzung, 1977; Bean et al., 1983; Matsubara and Hondeghem, 1983; Hondeghem and Matsubara, 1984) . Additional actions of amiodarone also may be partially responsible for its effectiveness. These include lengthening of action potential duration and suppression of automaticity. It is well known that lengthening of action potential duration (especially in the presence of a drug that blocks inactivated channels) will lengthen the effective refractory period. This, in turn, will reduce the maximum possible rate of a tachycardia and increase the shortest possible coupling interval of an early extrasystole.
At the dosage studied, amiodarone abolished depolarization-induced automaticity over the whole range of more negative (-75 to -55 mV) and less negative and positive (-55 to +10 mV) diastolic potentials. In contrast, doses of quinidine and lido-Circulation Research/Vo/. 55, No. 3, September 1984 caine (Katzung, 1974; Grant and Katzung, 1976) that lead to a similar reduction of V max at stimulation frequencies of 3 Hz reduce depolarization-induced automaticity only at more negative potentials. The precise mechanism(s) by which amiodarone is so highly effective in suppressing depolarization-induced automaticity requires further study. Nevertheless, inhibition of automaticity in depolarized tissue may be partially responsible for amiodarone's clinical efficacy.
The duration of the action potential was lengthened in both acute and chronic experiments. Although there was no difference in the effect at the two acute concentrations of amiodarone, we hesitate to conclude that the acute effect of amiodarone upon action potential duration is not dose-dependent, since we did not expose each papillary muscle to the two drug concentrations. The greater action potential duration found in chronically treated animals may be explained by biological variability, a larger myocardial concentration of amiodarone, or, conceivably, by the presence of a metabolite of amiodarone with a greater effect on action potential duration. Our experiments were not designed to assess these possibilities.
There is a delay in onset of antiarrhythmic effect of orally administered amiodarone (Rosenbaum et al., 1976) . It is therefore important to note that we found no qualitative difference between results of chronic dosage and acute superfusion of amiodarone. Other investigators have documented early onset of electrophysiological and antiarrhythmic activity of intravenously administered amiodarone in humans (Holt et al., 1982) . It is reasonable to suppose that the delay of efficacy encountered during the initial phase of oral therapy with amiodarone in humans is the result of remarkably extensive extracardiac storage of the drug, rather than delayed accumulation of active metabolites.
Our experiments show that amiodarone is a cardiac sodium channel blocker with selective affinity for inactivated channels. In addition, amiodarone prolongs action potential duration and inhibits depolarization-induced automaticity. These actions probably account in large part for the clinical efficacy of amiodarone. The possibility that amiodarone affects other transmembrane currents should be evaluated.
